Efficacy and Safety of Rilzabrutinib in Patients With Chronic Spontaneous Urticaria: 12-Week Results From the RILECSU Phase 2 DoseRanging Study

被引：0
|
作者：
Maurer, Marcus [1 ]
Gimenez-Arnau, Ana [2 ]
Ferrucci, Silvia [3 ]
Mikol, Vincent [4 ]
Sun, Iris [5 ]
Mannent, Leda [4 ]
Gereige, Jessica [6 ]
机构：
[1] Charite Univ Med Berlin, Berlin, Germany
[2] Univ Pompeu Fabra, Hosp Mar & Res Inst, Barcelona, Spain
[3] Fdn IRCCS Ca Granda Osped Maggiore Policlin, SC Dermatol, Milan, Italy
[4] Sanofi, Chilly Mazarin, France
[5] Sanofi, Beijing, Peoples R China
[6] Sanofi, Cambridge, MA USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2024年 / 153卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
L38
引用
收藏
页码：AB373 / AB373
页数：1
相关论文
共 50 条
  • [31] Efficacy and Safety of 12-week Interferon-based Danoprevir Regimen in Patients with Genotype 1 Chronic Hepatitis C
    Wei, Lai
    Shang, Jia
    Ma, Yuanji
    Xu, Xiaoyuan
    Huang, Yan
    Guan, Yujuan
    Duan, Zhongping
    Zhang, Wenhong
    Gao, Zhiliang
    Zhang, Mingxiang
    Li, Jun
    Jia, Jidong
    Yang, Yongfeng
    Wen, Xiaofeng
    Wang, Maorong
    Jia, Zhansheng
    Ning, Bo
    Chen, Yongping
    Qi, Yue
    Du, Jie
    Jiang, Jianning
    Tong, Lixin
    Xie, Yao
    Wu, Jinzi J.
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2019, 7 (03) : 221 - 225
  • [32] Analgesic efficacy and safety of Tramadol-Contramid® OAD:: A 12-week study in osteoarthritis
    Bouchard, S.
    Skinner-Robertson, S. A.
    Fortier, L.
    Kistler, C. J.
    Ellerbusch, M. T.
    Aparicio, R. T.
    Swami, S. S.
    Uy, C. N.
    Shirley, M.
    Jain, A. K.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 493 - 494
  • [33] Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study
    Cooper, Nichola
    Jansen, A. J. Gerard
    Bird, Robert
    Mayer, Jiri
    Sholzberg, Michelle
    Tarantino, Michael D.
    Garg, Mamta
    Ypma, Paula F.
    Mcdonald, Vickie
    Percy, Charles
    Kostal, Milan
    Goncalves, Isaac
    Bogdanov, Lachezar H.
    Gernsheimer, Terry B.
    Diab, Remco
    Yao, Mengjie
    Daak, Ahmed
    Kuter, David J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2025, 100 (03) : 439 - 449
  • [34] EFFICACY AND SAFETY OF 12-WEEK SOFOSBUVIR/VELPATASVIR THERAPY IN CHRONIC HEPATITIS C PATIENTS WITH DIFFERENT HCV GENOTYPES INFECTION: A PROSPECTIVE STUDY FROM THE REAL WORLD
    Chen, Enqiang
    Zhang, Dong-Mei
    Liu, Miao
    Tang, Hong
    HEPATOLOGY, 2022, 76 : S375 - S376
  • [35] Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
    Maurer, Marcus
    Ensina, Luis Felipe
    Gimenez-Arnau, Ana Maria
    Sussman, Gordon
    Hide, Michihiro
    Saini, Sarbjit
    Grattan, Clive
    Fomina, Daria
    Rigopoulos, Dimitrios
    Berard, Frederic
    Canonica, Giorgio Walter
    Rockmann, Heike
    Irani, Carla
    Szepietowski, Jacek C.
    Leflein, Jeffrey
    Bernstein, Jonathan A.
    Peter, Jonny G.
    Kulthanan, Kanokvalai
    Godse, Kiran
    Ardusso, Ledit
    Ukhanova, Olga
    Staubach, Petra
    Sinclair, Rodney
    Gogate, Shaila
    Thomsen, Simon Francis
    Tanus, Tonny
    Ye, Young Min
    Burciu, Alis
    Barve, Avantika
    Modi, Darshna
    Scosyrev, Emil
    Hua, Eva
    Letzelter, Kerstin
    Varanasi, Vineeth
    Patekar, Manmath
    Severin, Thomas
    LANCET, 2024, 403 (10422): : 147 - 159
  • [36] EPIDEMIOLOGIC DATA OF PATIENTS TREATED WITH FLUVOXAMINE - RESULTS FROM A 12-WEEK NONCOMPARATIVE MULTICENTER STUDY
    DEWULF, L
    HENDRICKX, B
    LESAFFRE, E
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1995, 9 : 67 - 72
  • [37] RELAMORELIN IN PATIENTS WITH DIABETIC GASTROPARESIS: EFFICACY AND SAFETY RESULTS FROM A PHASE 2B RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 12-WEEK STUDY (RM-131-009)
    Camilleri, Michael
    McCallum, Richard W.
    Tack, Jan F.
    Spence, Sharon C.
    Gottesdiener, Keith
    Fiedorek, Fred T.
    GASTROENTEROLOGY, 2017, 152 (05) : S139 - S140
  • [38] Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one-year extension study
    Maurer, Marcus
    Gimenez-Arnau, Ana
    Bernstein, Jonathan A.
    Chu, Chia-Yu
    Danilycheva, Inna
    Hide, Michihiro
    Makris, Michael
    Metz, Martin
    Savic, Sinisa
    Sitz, Karl
    Soong, Weily
    Staubach, Petra
    Sussman, Gordon
    Barve, Avantika
    Burciu, Alis
    Hua, Eva
    Janocha, Reinhold
    Severin, Thomas
    ALLERGY, 2022, 77 (07) : 2175 - 2184
  • [39] A 12-week phase 3 study of efficacy and safety of etanercept therapy in children and adolescents with moderate to severe plaque psoriasis
    Paller, Amy
    Siegfried, Elaine
    Langley, Richard
    Gottlieb, Alice
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB195 - AB195
  • [40] Adalimumab efficacy and safety in patients with moderate to severe chronic plaque psoriasis: Preliminary findings from a 12-week dose-ranging trial
    Chen, DM
    Gordon, K
    Leonardi, C
    Menter, MA
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P1 - P1
12345